Back to Results

An Open-Label, Multicenter, First-in-Human, Dose-Escalation Phase 1 Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Study category: Cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Eligibility

expansion is limited to malignant pleural mesothelioma, gastric adenocarcinoma and colorectal adenocarcinoma

Type of Study

Treatment

Location

University of Colorado Hospital

Principal Investigator
Chris Lieu,  MD

Chris Lieu, MD

Study ID

Protocol Number: 18-1672

More information available at ClinicalTrials.gov: NCT03715933

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers